APA Citation

Lingvay, I., Harris, S., Jaeckel, E., Chandarana, K., Ranthe, M. F., & Jódar, E. (2017). Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial. Diabetes Obes Metab.

Chicago Style Citation

Lingvay, Ildiko, Stewart Harris, Elmar Jaeckel, Keval Chandarana, Mattis F. Ranthe, and Esteban Jódar. "Insulin Degludec/liraglutide (IDegLira) Was Effective Across a Range of Dysglycaemia and Body Mass Index Categories in the DUAL V Randomized Trial." Diabetes Obes Metab 2017.

MLA Citation

Lingvay, Ildiko, et al. "Insulin Degludec/liraglutide (IDegLira) Was Effective Across a Range of Dysglycaemia and Body Mass Index Categories in the DUAL V Randomized Trial." Diabetes Obes Metab 2017.

Warning: These citations may not always be 100% accurate.